fda glp-1 warning news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Congress Introduces SAFE Drugs Act

Annu Rev Public Health

Because treatment typically begins with a lower dose, the body has time to adapt safely

Pharmacy Informatics Specialists Include a drugdrug interaction (or drug-procedure interaction) between GLP-1 receptor agonists and medications used for general anesthesia in the computerized prescribing, pharmacy, and medication administration systems, to alert practitioners of the aspiration risk

Despite these issues, industry sentiment is that gaps in adoption are closing rapidly

Supplements like Pure Encapsulations O.N.E

1 In the 1980s, Habener was working at Massachusetts General Hospital (MGH) and studying hormones, including glucagon, which increases blood glucose, in type 2 diabetes